Innovative online education platform helping global healthcare professionals address non-communicable diseases
PITTSBURGH and WASHINGTON, April 6, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and the American College of Cardiology (ACC) today released the latest NCD Academy course, Health Equity and Social Determinants of Health in NCDs, coinciding with World Health Day and the theme "Health for All." The NCD Academy is a user-friendly, interactive online platform developed by the ACC in partnership with the NCD Alliance and the World Heart Federation and sponsored by Viatris. The program is designed to equip primary healthcare professionals with educational resources and skills to enhance their ability to prevent and treat non-communicable diseases (NCDs). The NCD Academy's overarching goal is aligned with the vision to make health for all a reality, by providing continued education for skilled health workers and supporting people-centered care.
Health equity, as described by the WHO Commission on Social Determinants of Health (CSDH), is the absence of inequalities in healthcare that are avoidable by reasonable means. The new Health Equity and Social Determinants of Health in NCDs course aims to educate and increase awareness of health inequities and provide support on how to address them to achieve equitable care for all. Course topics led by leading experts in global health equity include an overview of social determinants of health; a closer look at the impact of structural discrimination; and strategies for tackling disparities in vulnerable communities, as well as low- and middle-income countries.
"Health equity and broadening access to healthcare is core to Viatris' mission of empowering people worldwide to live healthier at every stage of life. We are proud to collaborate with our NCD Academy partners to support the launch of the new course on Health Equity, as part of our continuing efforts to deliver access to health education on a global level," said Lobna Salem, Head of Medical Affairs, Developed Markets. "NCDs account for over 70% of deaths globally, many of which are preventable. Viatris is committed to helping to reduce this number, as demonstrated through one of our initial sustainability goals announced in our 2021 Sustainability Report: to impact 100 million patients via HCP education and outreach regarding prevention, diagnosis and treatment options for cardiovascular disease, diabetes, cancer and other important chronic conditions to improve outcomes through the NCD Academy by the end of 2025."
Launched in 2020, the NCD Academy features courses on nearly all aspects of NCDs, including cardiovascular disease and cancer. More recent courses also address mental health and advocacy and their respective roles in the NCD crisis, from which no country is immune. The new Health Equity course is being rolled out throughout the month of April, available at ACC.org/NCDAcademy.
"Health equity is a critical global health issue that must be addressed if we are to truly stem the tide of NCDs," said Dipti Itchhaporia, MD, MACC, former ACC president and a past chair of the College's Health Equity Task Force. "Transforming cardiovascular care and improving heart health for all needs to start with solving for health equity. The ACC is proud to partner with Viatris, WHF and NCD Alliance to drive awareness and action around this important topic. Together we are delivering global education that inspires global action and, while there is still much work to be done, it is exciting to see how far we've come to date."
For more information about the NCD Academy and to view available courses visit ACC.org/NCDAcademy.
About the NCD Academy
NCD Academy equips healthcare professionals, such as general practitioners, internists, nurses and community health workers, with high-quality continuing education available anytime, anywhere, and free of charge on fundamental skills to prevent, manage and mitigate today's leading causes of death and disability. Courses address non-communicable diseases (NCDs) through an intersectional lens given shared risk factors and the tendency of NCDs to coexist with one another, as well as with infectious diseases. Courses include eLearning that emulates the experience of intensive face-to-face training through interactive knowledge application and practice in the form of patient cases and games such as trivia. The Academy has hosted 44 trainings, equipping more than 70,000 health care professionals across ten countries with the latest science, technology, resources and tools to manage and prevent NCDs. The program has reached physicians and patients across many countries including Argentina, China, Colombia, Egypt, India, Iraq, Mexico, Peru, the Philippines, Saudi Arabia, Spain and the United States.
About the American College of Cardiology
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at ACC.org or follow @ACCinTouch.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ncd-academy-launches-new-health-equity-and-social-determinants-of-health-course-301791332.html
SOURCE Viatris Inc.
ACC: Nicole Napoli, nnapoli@acc.org; Viatris: Media: +1.724.514.1968, Communications@viatris.com; Matt Klein, Matthew.Klein@viatris.com; Investors: +1.724.514.1813, InvestorRelations@viatris.com; Bill Szablewski, William.Szablewski@viatris.com
